Tag: Jack Mycka

What impact will Trump’s most-favored-nation approach have on US drug pricing?

October 20, 2020
Read More

A 10-year review (2009-2018) of market access of pharmaceuticals in the EU5 and US.

December 1, 2019
Read More

ISPOR Pricing Short Courses with Jack Mycka and Renato Dellamano at ISPOR Annual International Meeting May 2019

November 5, 2019
Read More

Market access trends across the EU5 and US: 2009 to 2018 – an update.

June 1, 2019
Read More

EU5 market access for medicines approved under exceptional circumstances.

December 1, 2018
Read More

Market access trends for advanced therapy medicinal products (ATMPs) in Europe.

December 1, 2018
Read More

EU5 market access for medicines with conditional marketing authorisations.

December 1, 2018
Read More

Jack Mycka Teaches Pricing Short Course at ISPOR Europe 2018 in Barcelona, November 10-14

November 21, 2018
Read More

Pricing Short Courses with Jack Mycka at ISPOR Asia Pacific 2018 in Tokyo, September 8-11

June 13, 2018
Read More
Categories

let's talk!